IP Library › Granted Patent US 12,377,204
Granted Patent B2
US 12,377,204 · App. 19/077,384 · Granted Aug 5, 2025

System and method for collecting plasma

Inventor: Michael Ragusa (Hingham, MA)
Assignee: Haemonetics Corporation
A61M1/38A61M1/3644A61M1/385A61M1/3496A61M1/3626A61M1/3672A61M1/3693A61M2202/0415A61M2205/3306A61M2205/3379A61M2205/3393A61M2230/207
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,377,204
App. No.
19/077,384
Granted
Aug 5, 2025
Kind
B2
Abstract

A method for collecting plasma includes determining the weight, height, and hematocrit of a donor, and calculating a donor plasma volume and a target plasma collection volume. The target plasma collection volume is based on the donor plasma volume and a target percentage of plasma. The method then withdraws blood from the donor through a line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate the volume of pure plasma collected within the plasma collection container, and continue processing/collecting until the calculated volume of pure plasma equals the target plasma collection volume.

Claims (64)

1. A method for collecting plasma comprising:

calculating a donor total blood volume based, at least in part, on a weight and a height of a donor;

calculating a target plasma amount to collect based, at least in part, on the calculated donor total blood volume and a hematocrit of the donor, the target plasma amount to collect tailored to the donor;

withdrawing whole blood from the donor through a venous-access device and a first line, the first line connected to a blood component separation device of a blood processing system, the blood processing system having a controller configured to stop collecting plasma when the target plasma amount to collect has been collected into a plasma collection container;

introducing anticoagulant into the withdrawn whole blood through an anticoagulant line;

separating the withdrawn whole blood into a plasma component and at least a second blood component; and

collecting the plasma component from the blood component separation device into the plasma collection container until the target plasma amount to collect is reached in the plasma collection container.

2. The method according to claim 1 , further comprising:

calculating the donor's body mass index based, at least in part on the weight and the height of the donor, the target plasma amount to collect calculated based, at least in part, on the donor's body mass index.

3. The method according to claim 1 , wherein the calculated target plasma amount to collect is an optimized safe amount to be collected from the donor.

4. The method according to claim 1 , further comprising:

returning, after collecting at least a portion of the target plasma amount to collect, the contents of the blood component separation device to the donor through the first line.

5. The method according to claim 1 , wherein the target plasma amount to collect is a target amount of pure plasma to collect.

6. The method according to claim 1 , wherein the target plasma amount to collect is a target amount of anticoagulated plasma to collect.

7. The method according to claim 1 , further comprising:

monitoring an amount of plasma component collected within the plasma collection container.

8. A system for collecting plasma comprising:

a venous-access device for drawing whole blood from a donor and returning blood components to the donor;

a blood component separation device for separating the drawn whole blood into a plasma component and at least a second blood component, the blood component separation device having an outlet and being configured to send the plasma component to a plasma collection container;

a first line fluidly connected to the venous-access device and configured to transport drawn whole blood to the blood component separation device and return fluid within the blood component separation device to the donor, the flow through the first line being controlled by a first pump;

an anticoagulant line connected to an anticoagulant source, the anticoagulant line configured to introduce anticoagulant into the drawn whole blood; and

a controller configured to control the operation of the blood component separation device and the first pump, the controller configured to calculate a target plasma amount to collect based, at least in part, on the donor's total blood volume and a hematocrit of the donor, the donor's total blood volume based, at least in part, on a weight and height of the donor, the target plasma amount to collect tailored to the donor.

9. The system according to claim 8 , wherein the controller is further configured to stop collecting plasma when the target amount of plasma to collect has been collected into the plasma collection container.

10. The system according to claim 8 , wherein the controller is further configured to:

calculate the donor's body mass index based, at least in part on the weight and height of the donor, the target plasma amount to collect calculated based, at least in part, on the donor's body mass index.

11. The system according to claim 8 , wherein the controller is further configured to calculate the donor's total blood volume.

12. The system according to claim 8 , wherein the calculated target plasma amount to collect is an optimized safe amount to be collected from the donor.

13. The system according to claim 8 , wherein the controller is further configured to:

return, after collecting at least a portion of the target plasma amount to collect, the contents of the blood component separation device to the donor through the first line.

14. The system according to claim 8 , wherein the target plasma amount to collect is a target amount of pure plasma to collect or a target amount of anticoagulated plasma to collect.

15. A method for collecting plasma comprising:

determining individual characteristics of a donor, the individual characteristics of the donor including a weight, a height and a hematocrit of the donor;

calculating a donor total blood volume based, at least in part, on the weight and height of the donor;

calculating a target plasma amount to collect based, at least in part, on the calculated donor total blood volume and the hematocrit of the donor, the target plasma amount to collect being tailored to the individual characteristics of the donor;

withdrawing whole blood from the donor through a venous-access device and a first line, the first line connected to a blood component separation device;

introducing anticoagulant into the withdrawn whole blood through an anticoagulant line;

separating the withdrawn whole blood into a plasma component and at least a second blood component; and

collecting the plasma component from the blood component separation device and into a plasma collection container.

16. The method according to claim 15 , further comprising:

calculating the donor's body mass index based, at least in part, on the weight and height of the donor, the target plasma amount to collect calculated based, at least in part, on the donor's body mass index.

17. The method according to claim 15 , further comprising:

returning, after collecting at least a portion of the target plasma amount to collect, the contents of the blood component separation device to the donor through the first line.

18. The method according to claim 15 , wherein the target plasma amount to collect is a target amount of pure plasma to collect.

19. The method according to claim 15 , wherein the target plasma amount to collect is a target amount of anticoagulated plasma to collect.

20. The method according to claim 15 , wherein the target plasma amount to collect is an optimized safe amount to be collected from the donor.

21. The method according to claim 15 , further comprising:

stopping the collection of the plasma component from the blood component separation device into the plasma collection container when the target plasma amount to collect is reached in the plasma collection container.

22. The method according to claim 15 , wherein the blood component separation device is part of a blood processing system, the blood processing system having a controller configured to stop collecting the plasma component when the target plasma amount to collect has been collected into the plasma collection container.

23. A system for collecting plasma comprising:

a venous-access device for drawing whole blood from a donor and returning blood components to the donor;

a blood component separation device for separating the drawn whole blood into a plasma component and at least a second blood component, the blood component separation device having an outlet and being configured to send the plasma component to a plasma collection container;

a first line fluidly connected to the venous-access device and configured to transport drawn whole blood to the blood component separation device and return fluid within the blood component separation device to the donor, the flow through the first line being controlled by a first pump;

an anticoagulant line connected to an anticoagulant source, the anticoagulant line configured to introduce anticoagulant into the drawn whole blood; and

a controller configured to control the operation of the blood component separation device and the first pump, the controller configured to (1) receive individual characteristics of the donor, the individual characteristics including a weight, height, and hematocrit of the donor, and (2) calculate a target plasma amount to collect based, at least in part, on the donor's total blood volume and a hematocrit of the donor, the donor's total blood volume based, at least in part, on the weight and height of the donor, the target plasma amount to collect being tailored to the individual characteristics of the donor.

24. The system of claim 23 , wherein the controller is further configured to calculate the donor's total blood volume.

25. The system according to claim 23 , wherein the controller is further configured to stop collecting the plasma component when the target amount of plasma to collect has been collected into the plasma collection container.

26. The system according to claim 23 , wherein the controller is further configured to:

calculate the donor's body mass index based, at least in part on the weight and height of the donor, the target plasma amount to collect calculated based, at least in part, on the donor's body mass index.

27. The system according to claim 23 , wherein the controller is further configured to:

return, after collecting at least a portion of the target plasma amount to collect, the contents of the blood component separation device to the donor through the first line.

28. The system according to claim 23 , wherein the target plasma amount to collect is a target amount of pure plasma to collect or a target amount of anticoagulated plasma to collect.

29. The system according to claim 23 , wherein the target plasma amount to collect is an optimized safe amount to be collected from the donor.

30. The system according to claim 23 , further comprising:

a plasma collection container weight sensor configured to monitor a volume or weight of plasma component collected within the plasma collection container.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2025
From: RAGUSA, MICHAEL
To: HAEMONETICS CORPORATION
Reel/Frame 070488/0491 →
Continuity (6)
Continuation 18606761 · Mar 15, 2024
Continuation 17205400 · Mar 18, 2021
Continuation 16931333 · Jul 16, 2020
Continuation 15793339 · Oct 25, 2017
Continuation In Part 15608183 · May 30, 2017
Related Publication 20250205408A1 · Jun 26, 2025
References Cited (263)
US 1025059A · Hatton et al. · 1912 [cited by applicant]
US 1611725A · Degerth et al. · 1926 [cited by applicant]
US 2087778A · Nelin · 1937 [cited by applicant]
US 2661150A · Abbott, Jr. · 1953 [cited by applicant]
US 2750107A · More · 1956 [cited by applicant]
US 2792172A · Tait · 1957 [cited by applicant]
US 3096283A · Hein · 1963 [cited by applicant]
US 3145713A · Latham, Jr. · 1964 [cited by applicant]
US 3239136A · Hein · 1966 [cited by applicant]
US 3244362A · Hein · 1966 [cited by applicant]
US 3244363A · Hein · 1966 [cited by applicant]
US 3409213A · Latham, Jr. · 1968 [cited by applicant]
US 3456875A · Hein · 1969 [cited by applicant]
US 3489145A · Judson et al. · 1970 [cited by applicant]
US 3565330A · Latham, Jr. · 1971 [cited by applicant]
US 3655058A · Novak · 1972 [cited by applicant]
US 3737096A · Jones et al. · 1973 [cited by applicant]
US 3774840A · Boatright · 1973 [cited by applicant]
US 3987961A · Sinn et al. · 1976 [cited by applicant]
US 4007871A · Jones et al. · 1977 [cited by applicant]
US 4010894A · Kellogg et al. · 1977 [cited by applicant]
US 4014497A · Spiewok et al. · 1977 [cited by applicant]
US 4040965A · Kohlheb · 1977 [cited by applicant]
US 4056224A · Lolachi · 1977 [cited by applicant]
US 4082217A · Westberg · 1978 [cited by applicant]
US 4086924A · Latham, Jr. · 1978 [cited by applicant]
US 4140268A · Lacour · 1979 [cited by applicant]
US 4142670A · Ishimaru et al. · 1979 [cited by applicant]
US 4151844A · Cullis et al. · 1979 [cited by applicant]
US 4197847A · Djerassi · 1980 [cited by applicant]
US 4285464A · Latham, Jr. · 1981 [cited by applicant]
US 4300717A · Latham, Jr. · 1981 [cited by applicant]
US 4303193A · Latham, Jr. · 1981 [cited by applicant]
US 4321921A · Laszczower · 1982 [cited by applicant]
US 4387848A · Kellogg et al. · 1983 [cited by applicant]
US 4425114A · Schoendorfer et al. · 1984 [cited by applicant]
US 4430072A · Kellogg et al. · 1984 [cited by applicant]
US 4447221A · Mulzet · 1984 [cited by applicant]
US 4457747A · Tu · 1984 [cited by applicant]
US 4464167A · Schoendorfer et al. · 1984 [cited by applicant]
US 4466888A · Verkaart · 1984 [cited by applicant]
US 4482342A · Lueptow et al. · 1984 [cited by applicant]
US 4490135A · Troutner · 1984 [cited by applicant]
US 4530691A · Brown · 1985 [cited by applicant]
US 4534863A · Bacon et al. · 1985 [cited by applicant]
US 4643714A · Brose · 1987 [cited by applicant]
US 4647279A · Mulzet et al. · 1987 [cited by applicant]
US 4655742A · Vantard · 1987 [cited by applicant]
US 4680025A · Kruger et al. · 1987 [cited by applicant]
US 4684361A · Feldman et al. · 1987 [cited by applicant]
US 4692136A · Feldman et al. · 1987 [cited by applicant]
US 4708712A · Mulzet · 1987 [cited by applicant]
US 4713176A · Schoendorfer et al. · 1987 [cited by applicant]
US 4734089A · Cullis · 1988 [cited by applicant]
US 4740202A · Stacey et al. · 1988 [cited by applicant]
US 4740313A · Schoendorfer et al. · 1988 [cited by applicant]
US 4755300A · Fischel et al. · 1988 [cited by applicant]
US 4767396A · Powers · 1988 [cited by applicant]
US 4795419A · Yawn et al. · 1989 [cited by applicant]
US 4795448A · Stacey et al. · 1989 [cited by applicant]
US 4806247A · Schoendorfer et al. · 1989 [cited by applicant]
US 4806252A · Brown et al. · 1989 [cited by applicant]
US 4808307A · Fischel et al. · 1989 [cited by applicant]
US 4850995A · Tie et al. · 1989 [cited by applicant]
US 4869812A · Schoendorfer et al. · 1989 [cited by applicant]
US 4871462A · Fischel et al. · 1989 [cited by applicant]
US 4876013A · Shmidt et al. · 1989 [cited by applicant]
US 4889524A · Fell et al. · 1989 [cited by applicant]
US 4911833A · Schoendorfer et al. · 1990 [cited by applicant]
US 4934995A · Cullis · 1990 [cited by applicant]
US 4940543A · Brown et al. · 1990 [cited by applicant]
US 4943273A · Pages · 1990 [cited by applicant]
US 4968295A · Neumann · 1990 [cited by applicant]
US 4983156A · Knelson · 1991 [cited by applicant]
US 4983158A · Headley · 1991 [cited by applicant]
US 4985153A · Kuroda et al. · 1991 [cited by applicant]
US 4994188A · Prince · 1991 [cited by applicant]
US 5039401A · Columbus et al. · 1991 [cited by applicant]
US 5045048A · Kaleskas et al. · 1991 [cited by applicant]
US 5098372A · Jonsson · 1992 [cited by applicant]
US 5098373A · Polaschegg · 1992 [cited by applicant]
US 5100372A · Headley · 1992 [cited by applicant]
US 5100564A · Pall et al. · 1992 [cited by applicant]
US 5112298A · Prince et al. · 1992 [cited by applicant]
US 5114396A · Unger et al. · 1992 [cited by applicant]
US 5135667A · Schoendorfer · 1992 [cited by applicant]
US 5141486A · Antwiler · 1992 [cited by applicant]
US 5147290A · Jonsson · 1992 [cited by applicant]
US 5154716A · Bauman et al. · 1992 [cited by applicant]
US 5174894A · Ohsawa et al. · 1992 [cited by applicant]
US 5194145A · Schoendorfer · 1993 [cited by applicant]
US 5217426A · Bacehowski et al. · 1993 [cited by applicant]
US 5217427A · Cullis · 1993 [cited by applicant]
US 5234403A · Yoda et al. · 1993 [cited by applicant]
US 5254248A · Nakamura · 1993 [cited by applicant]
US 5273517A · Barone et al. · 1993 [cited by applicant]
US 5277701A · Christie et al. · 1994 [cited by applicant]
US 5298016A · Gordon · 1994 [cited by applicant]
US 5298171A · Biesel · 1994 [cited by applicant]
US 5300060A · Nelson · 1994 [cited by applicant]
US 5316540A · McMannis et al. · 1994 [cited by applicant]
US 5318511A · Riquier et al. · 1994 [cited by applicant]
US 5318512A · Neumann · 1994 [cited by applicant]
US 5348533A · Papillon et al. · 1994 [cited by applicant]
US 5368542A · McMannis et al. · 1994 [cited by applicant]
US 5368555A · Sussman et al. · 1994 [cited by applicant]
US 5386734A · Pusinelli · 1995 [cited by applicant]
US 5387174A · Rochat · 1995 [cited by applicant]
US 5387187A · Fell et al. · 1995 [cited by applicant]
US 5403272A · Deniega et al. · 1995 [cited by applicant]
US 5405308A · Headley et al. · 1995 [cited by applicant]
US 5417650A · Gordon · 1995 [cited by applicant]
US 5431814A · Jorgensen · 1995 [cited by applicant]
US 5437598A · Antwiler · 1995 [cited by applicant]
US 5437624A · Langley · 1995 [cited by applicant]
US 5462667A · Wollinsky et al. · 1995 [cited by applicant]
US 5470483A · Bene et al. · 1995 [cited by applicant]
US 5484396A · Naficy · 1996 [cited by applicant]
US 5494592A · Latham, Jr. et al. · 1996 [cited by applicant]
US 5505685A · Antwiler · 1996 [cited by applicant]
US 5514070A · Pages · 1996 [cited by applicant]
US 5543062A · Nishimura · 1996 [cited by applicant]
US 5551941A · Howell · 1996 [cited by applicant]
US 5585007A · Antanavich et al. · 1996 [cited by applicant]
US 5607579A · Latham, Jr. et al. · 1997 [cited by applicant]
US 5649903A · Deniega et al. · 1997 [cited by applicant]
US 5651766A · Kingsley et al. · 1997 [cited by applicant]
US 5656163A · Brown · 1997 [cited by applicant]
US 5665061A · Antwiler · 1997 [cited by applicant]
US 5681273A · Brown · 1997 [cited by applicant]
US 5712798A · Langley et al. · 1998 [cited by applicant]
US 5728060A · Kingsley et al. · 1998 [cited by applicant]
US 5733253A · Headley et al. · 1998 [cited by applicant]
US 5733446A · Holm · 1998 [cited by applicant]
US 5733545A · Hood, III · 1998 [cited by applicant]
US 5738792A · Schoendorfer · 1998 [cited by applicant]
US 5762791A · Deniega et al. · 1998 [cited by applicant]
US 5779660A · Kingsley et al. · 1998 [cited by applicant]
US 5783085A · Fischel · 1998 [cited by applicant]
US 5792351A · Wehrle et al. · 1998 [cited by applicant]
US 5849203A · Brown et al. · 1998 [cited by applicant]
US 5882289A · Sakota et al. · 1999 [cited by applicant]
US 5906589A · Gordon et al. · 1999 [cited by applicant]
US 5919125A · Berch · 1999 [cited by applicant]
US 5964724A · Rivera et al. · 1999 [cited by applicant]
US 5970432A · Ishimoto et al. · 1999 [cited by applicant]
US 5980760A · Min et al. · 1999 [cited by applicant]
US 6007725A · Brown · 1999 [cited by applicant]
US 6059979A · Brown · 2000 [cited by applicant]
US 6200287B1 · Keller et al. · 2001 [cited by applicant]
US 6207063B1 · Brown · 2001 [cited by applicant]
US 6234989B1 · Brierton et al. · 2001 [cited by applicant]
US 6296602B1 · Headley · 2001 [cited by applicant]
US 6464624B2 · Pages · 2002 [cited by applicant]
US 6497676B1 · Childers et al. · 2002 [cited by applicant]
US 6558307B2 · Headley · 2003 [cited by applicant]
US 6623443B1 · Polaschegg · 2003 [cited by applicant]
US 6743192B1 · Sakota et al. · 2004 [cited by applicant]
US 7115205B2 · Robinson et al. · 2006 [cited by applicant]
US 7186231B2 · Takagi et al. · 2007 [cited by applicant]
US 7270645B2 · Langley et al. · 2007 [cited by applicant]
US 7704454B1 · Langley et al. · 2010 [cited by applicant]
US 8075468B2 · Min et al. · 2011 [cited by applicant]
US 8454548B2 · Ohashi et al. · 2013 [cited by applicant]
US 8628489B2 · Pages et al. · 2014 [cited by applicant]
US 8702637B2 · Pages et al. · 2014 [cited by applicant]
US 8759094B2 · Ranby · 2014 [cited by applicant]
US 9283316B2 · Flexman · 2016 [cited by applicant]
US 10758652B2 · Ragusa · 2020 [cited by applicant]
US 10792416B2 · Ragusa · 2020 [cited by examiner]
US 10980926B2 · Ragusa · 2021 [cited by applicant]
US 10980934B2 · Ragusa · 2021 [cited by applicant]
US 11738124B2 · Ragusa · 2023 [cited by applicant]
US 12171916B2 · Ragusa · 2024 [cited by applicant]
US 12186474B2 · Ragusa · 2025 [cited by examiner]
US 20010000185A1 · Keller et al. · 2001 [cited by applicant]
US 20010027156A1 · Egozy et al. · 2001 [cited by applicant]
US 20020043492A1 · Bischof · 2002 [cited by applicant]
US 20020062100A1 · Pierce et al. · 2002 [cited by applicant]
US 20020120227A1 · Childers et al. · 2002 [cited by applicant]
US 20030055375A1 · Holst et al. · 2003 [cited by applicant]
US 20030066807A1 · Suzuki · 2003 [cited by applicant]
US 20030125881A1 · Ryan · 2003 [cited by applicant]
US 20030175150A1 · Grimm · 2003 [cited by applicant]
US 20040186409A1 · Cavalcanti et al. · 2004 [cited by applicant]
US 20050131334A1 · Langley et al. · 2005 [cited by applicant]
US 20050209522A1 · Tadokoro et al. · 2005 [cited by applicant]
US 20050235733A1 · Holst et al. · 2005 [cited by applicant]
US 20060058167A1 · Ragusa et al. · 2006 [cited by applicant]
US 20060155236A1 · Gara et al. · 2006 [cited by applicant]
US 20060226086A1 · Robinson et al. · 2006 [cited by applicant]
US 20070112289A1 · Cavalcanti et al. · 2007 [cited by applicant]
US 20080146993A1 · Krishna · 2008 [cited by applicant]
US 20120165685A1 · Weasler et al. · 2012 [cited by applicant]
US 20120175313A1 · Barry, Jr. · 2012 [cited by examiner]
US 20140039373A1 · Ragusa et al. · 2014 [cited by applicant]
US 20140100507A1 · Flexman · 2014 [cited by applicant]
US 20140356851A1 · Pages et al. · 2014 [cited by applicant]
US 20180344910A1 · Ragusa · 2018 [cited by applicant]
US 20200261630A1 · Ragusa · 2020 [cited by applicant]
US 20240293604A1 · Ragusa · 2024 [cited by applicant]
CN 2735985Y · 2005 [cited by applicant]
CN 103354755A · 2013 [cited by applicant]
DE 69434848 · 2007 [cited by applicant]
EP 0128683A2 · 1984 [cited by applicant]
EP 0171749A1 · 1986 [cited by applicant]
EP 0208061A1 · 1987 [cited by applicant]
EP 257755A1 · 1988 [cited by applicant]
EP 0578086A1 · 1994 [cited by applicant]
EP 619145A2 · 1994 [cited by applicant]
EP 0654277A1 · 1995 [cited by applicant]
EP 664159A1 · 1995 [cited by applicant]
EP 799645A1 · 1997 [cited by applicant]
EP 0885619A1 · 1998 [cited by applicant]
EP 1057534A1 · 2000 [cited by applicant]
EP 1128887A1 · 2001 [cited by applicant]
EP 1295619A2 · 2003 [cited by applicant]
EP 1374927A1 · 2004 [cited by applicant]
FR 2258898A1 · 1975 [cited by applicant]
GB 2047110A · 1980 [cited by applicant]
JP S59006952A · 1984 [cited by applicant]
JP S59069166A · 1984 [cited by applicant]
JP H02052665A · 1990 [cited by applicant]
JP H03131268A · 1991 [cited by applicant]
JP H07075746A · 1995 [cited by applicant]
JP H08131539A · 1996 [cited by applicant]
JP H09192215A · 1997 [cited by applicant]
JP 2002282352A · 2002 [cited by applicant]
JP 2002291872A · 2002 [cited by applicant]
JP 2003516175A · 2003 [cited by applicant]
JP 2008506424A · 2008 [cited by applicant]
JP 2021500950A · 2021 [cited by applicant]
RU 2252788C1 · 2005 [cited by applicant]
RU 2601449C2 · 2016 [cited by applicant]
SU 660718A1 · 1979 [cited by applicant]
SU 762982A1 · 1980 [cited by applicant]
SU 1146098A1 · 1985 [cited by applicant]
WO 198502561A1 · 1985 [cited by applicant]
WO 199000059A1 · 1990 [cited by applicant]
WO 199007383A1 · 1990 [cited by applicant]
WO 199406535A1 · 1994 [cited by applicant]
WO 199611747A2 · 1996 [cited by applicant]
WO 199633023A1 · 1996 [cited by applicant]
WO 200205059A2 · 2002 [cited by applicant]
WO 2007041716A1 · 2007 [cited by applicant]
WO 2011028887A2 · 2011 [cited by applicant]
WO 2012091720A1 · 2012 [cited by applicant]
WO 2019084278A1 · 2019 [cited by applicant]
U.S. Appl. No. 15/608,183, filed May 30, 2017, U.S. Pat. No. 10,758,652, Issued. [cited by applicant]
U.S. Appl. No. 16/866,078, filed May 4, 2020, U.S. Pat. No. 10,980,926, Issued. [cited by applicant]
U.S. Appl. No. 17/205,374, filed Mar. 18, 2021, U.S. Pat. No. 12,171,916, Issued. [cited by applicant]
U.S. Appl. No. 17/943,410, filed Sep. 13, 2022, U.S. Pat. No. 11,738,124, Issued. [cited by applicant]
U.S. Appl. No. 18/955,269, filed Nov. 21, 2024, Pending. [cited by applicant]
U.S. Appl. No. 15/793,339, filed Oct. 25, 2017, U.S. Pat. No. 10,792,416, Issued. [cited by applicant]
U.S. Appl. No. 16/931,333, filed Jul. 16, 2020, U.S. Pat. No. 10,980,934, Issued. [cited by applicant]
U.S. Appl. No. 17/205,400, filed Mar. 18, 2021, U.S. Pat. No. 12,186,474, Issued. [cited by applicant]
U.S. Appl. No. 18/606,761, filed Mar. 15, 2024, 2024-0293604, Published. [cited by applicant]
Haemonetics Nomogram—Male, 2 pages, May 1990. [cited by applicant]
Lemmens et al., Estimating blood volume in obese and morbidly obese patients. Obes Surg. Jun. 2006;16(6):773-6. [cited by applicant]
Nadler et al., Prediction of blood vol. in normal human adults. Surgery. Feb. 1962;51(2):224-32. [cited by applicant]
Winters, Complications of donor apheresis. J Clin Apher. Jul. 2006;21(2):132-41. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/033826, dated Aug. 3, 2018, 10 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/057528, dated Jan. 7, 2019, 17 pages. [cited by applicant]